Search Results for 'patients aml'
patients aml published presentations and documents on DocSlides.
The new (2021) ELN AML MRD guidelines
by sylvia
Yishai Ofran 2021. The general idea of MRD measure...
Inherited bone marrow failure syndromes
by amelia
Josu. de la . Fuente. Departments of Paediatrics ...
Page 2 of 4McGrathand Smink J Med Case Reports 2021 15228
by isabella
signi cance di cult to ascertain []. ere are nume...
Updated Results From a Phase 2 Study of Pracinostat in Combination Wit
by melody
BACKGROUNDElderly patients with acute myeloid leuk...
Please note, these are the actual video-recorded
by likets
proceedings from the live CME event and may includ...
Azacitidine use in post transplant relapse of MDS and AML
by test
Jennifer Vaughn, MD. Bart Scott, MD. Myelodysplas...
11/03/14 Personalized Approach in Acute and Chronic Leukemias
by kittie-lecroy
Emmanuel C. Besa, M.D.. Professor of Medical Onco...
Understanding Evolving Treatment Paradigms for Older Adults
by alexa-scheidler
Farhad. . Ravandi. , . MD. Professor of Medicine...
Therapy-related acute myeloid leukaemia following treatment for cancer in childhood: a population-b
by thomas
Joanne Aitken, Danny Youlden, Cate Brown, Andy Moo...
Targeted therapies against Acute Myeloid Leukemia
by triclin
Hiba . El Hajj, Ph.D.. Assistant Professor, . Depa...
Investor Presentation Seeking $500,000 Convertible Note Financing,
by danika-pritchard
P. receding $13MM Series B Round . NON-CONFIDENT...
Targeted Therapy in Acute Myeloid Leukemia
by ellena-manuel
Ross . L. Levine M.D.. Human Oncology and Pathoge...
Diagnosis and management of acute myeloid leukemia in children and
by crunchingsubway
adolescents: recommendations from an international...
Recruitment of cancer patients by LCRN
by karlyn-bohler
Subspecialty: Haem . Onc. & Lymphoma . Recr...
x0000x0000 xMCIxD 0 xMCIxD 0 xMCIxD 1 x
by thomas
The results of the phase 3 QuANTUM
FLT3 inhibitor,...
Welcome! To join the call dial (866) 740-1260, passcode 3754894#.
by OptimisticPanda
All participants are placed on mute for the durati...
Targeting Disease at the Nuclear Pore
by yoshiko-marsland
Corporate Presentation. August 2015. NASDAQ: KPTI...
Identification of mutations prognostic of relapse after all
by test
P Ferguson, L . Quek. , M . Metzner. , I Ahmed, C...
Targeting Disease at the Nuclear Pore
by phoebe-click
Corporate Presentation. August 2015. NASDAQ: KPTI...
Evolving Therapies for Elderly Patients with Blood Cancers
by alida-meadow
Andrew Artz, MD, MS. Associate Professor of Medic...
Deep Learning for Distinguishing Morphological Features of Acute Promyelocytic Leukemia
by grace3
John-William . Sidhom. , MD/PhD Candidate ’21. D...
Key Presentations from the 63rd American Society of Hematology (ASH) Annual Meeting:
by danya
Acute Myeloid Leukemia and Myelodysplastic Syndrom...
Myelodysplastic syndromeGuru Subramanian Guru Murthy MDAssistant profe
by jalin
Clonal hematopoietic disorder multilineage hematop...
Focusing on Health Equity in Hematology
by ivy
. Press Briefing. Moderator: Alison Walker. , MD, ...
